Russell Investments Group, Ltd. Precision Biosciences Inc Transaction History

Russell Investments Group, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$1.15 - $3.34 $35,972 - $104,475	-31,280 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$2.96 - $7.76 $52,208 - $136,870	17,638 Added 129.29%	31,280 $96,000
Q4 2021 Jan 21, 2022	SELL	$7.4 - $11.66 $598,489 - $943,025	-80,877 Reduced 85.57%	13,642 $100,000
Q3 2021 Nov 08, 2021	SELL	$9.18 - $14.15 $77,782 - $119,892	-8,473 Reduced 8.23%	94,519 $1.09 Million
Q2 2021 Aug 04, 2021	BUY	$8.07 - $12.52 $484,506 - $751,675	60,038 Added 139.77%	102,992 $1.29 Million
Q1 2021 May 10, 2021	BUY	$8.57 - $15.79 $102,582 - $189,006	11,970 Added 38.63%	42,954 $444,000
Q4 2020 Feb 08, 2021	SELL	$5.98 - $12.47 $38,690 - $80,680	-6,470 Reduced 17.27%	30,984 $257,000
Q3 2020 Nov 09, 2020	BUY	$4.65 - $8.73 $164,861 - $309,513	35,454 Added 1772.7%	37,454 $230,000
Q2 2020 Aug 05, 2020	BUY	$4.66 - $8.7 $9,320 - $17,400	2,000 New	2,000 $16,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.